Adjuvant therapies for Parkinson’s disease: critical evaluation of safinamide
Fabrizio Stocchi, Margherita Torti Institute for Research and Medical Care, IRCCS San Raffaele Pisana, Rome, Italy Abstract: Safinamide (SAF) is a new drug developed for the treatment of Parkinson’s disease (PD). It is a benzylamino derivative with multiple mechanisms of action and antip...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2016-02-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/adjuvant-therapies-for-parkinsonrsquos-disease-critical-evaluation-of--peer-reviewed-article-DDDT |